Related Experiment Video
Updated: Sep 6, 2025

06:56
Influenza Virus Propagation in Embryonated Chicken Eggs
Published on: March 19, 2015
43.7K
MADE: A Computational Tool for Predicting Vaccine Effectiveness for the Influenza A(H3N2) Virus Adapted to
Hui Chen1, Junqiu Wang2,3, Yunsong Liu2,4
1Human Genomics, Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore 138672, Singapore.
Vaccines
|June 24, 2022
Summary
Seasonal influenza H3N2 virus vaccine effectiveness is suboptimal. This study introduces a computational tool, MADE, to measure egg passage adaptation and select better vaccine viruses, improving public health.
Area of Science:
- Virology
- Immunology
- Computational Biology
Background:
- Seasonal influenza H3N2 poses a significant public health risk, with current vaccine effectiveness (VE) being suboptimal.
- Viral passage in embryonated eggs is a critical step in influenza vaccine production.
- Egg passage adaptation, driven by convergent evolution in hemagglutinin (HA1), negatively impacts VE.
Purpose of the Study:
- To leverage the negative correlation between egg passage adaptation and VE.
- To develop a computational tool for selecting optimal candidate vaccine viruses (CVVs).
Main Methods:
- Utilized mutational mapping, a probabilistic approach, to analyze egg passage adaptation patterns.
- Developed a new metric, adaptive distance (AD), to quantify the strength of egg passage adaptation.
- Validated the correlation between AD and influenza H3N2 VE.
Main Results:
- Adaptive distance (AD) was found to be negatively correlated with influenza H3N2 vaccine effectiveness (VE).
- AD explained approximately 75% of the variability in VE.
- A computational package, MADE (Measure the Adaptive Distance and predict vaccine Effectiveness), was developed.
Conclusions:
- The MADE package offers a robust tool for assessing egg passage adaptation effects.
- It enables the selection of reliable influenza vaccine strains with minimal egg-passaged changes.
- This can lead to improved seasonal A/H3N2 influenza vaccine efficacy.

